Recombinant CD27 (Varlilumab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all CD27 (Varlilumab Biosimilar) products
- CD27 (Varlilumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This CD27 (Varlilumab Biosimilar) antibody is un-conjugated
- Application
- Please inquire
- Purpose
- Varlilumab Biosimilar - Anti-CD27, TNFRSF7 mAb
- Characteristics
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
anti-CD27 (Varlilumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- CD27 (Varlilumab Biosimilar)
- Abstract
- CD27 (Varlilumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- 1F5,CDX-1127
-
You are here:
